跳至主要内容
临床试验/CTRI/2025/07/091825
CTRI/2025/07/091825尚未招募2/3 期

RANDOMIZED CONTROLLED CLINICAL TRIAL OF ERAND TAILA YONIPICHU IN THE MANAGEMENT OF PARIPLUTA YONIVYAPAD WITH SPECIAL REFERENCE TO CHRONIC PELVIC INFLAMMATORY DISEASE.

Dr.Pallavi Dinkar Kamthe1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2025年8月9日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
70
试验地点
1
主要终点
Decrease In Sign And Symptom Of Yonidaha,Yonigat Strav,Katishoola,Ruja

研究概览

简要总结

Paripluta yonivyapad has been chosen for the present study which is seen in married women of reproductive age (21-50yrs). Need has always been felt to develop certain ayurvedic treatment modalities for the management of Paripluta Yonivyapad (Chronic Pelvic inflammatory Disease) which could be safe, effective, readily available, cost effective, without any side effects in comparison to the therapeutic procedures of different systems of medicine. Ayurveda has holistic approach towards the treatment of Paripluta Yonivyapad with their backgrounds an effort is made to evaluate the efficacy of Erand taila yoni pichu in series of patients suffering from Paripluta Yonivyapad (Chronic Pelvic inflammatory Disease). The Erand taila is having properties as vata kapha shamak,Madhur vipak,kashay rasa because of these properties it help to overcome the symptoms of Paripluta Yonivyapad by increasing local immunity and prevent recurrence of symptoms in patients

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
21.00 Year(s) 至 50.00 Year(s)(—)
性别
Female

入选标准

  • 1.Only Married women in between Age group of 21-50 yrs.
  • Patient having specific symptoms of chronic pelvic inflammatory disease like chronic pain in abdomen, previous history of acute pelvic inflammatory disease malaise associated with lower abdominal pain and tenderness.

排除标准

  • 1.Patients having Malignant or Benign tumor, Polyp, Fibroid, Endometriosis, Tubo-Ovarian Mass, Adenomyosis etc.
  • Pregnant women 3.Unmarried women 4.Known case of Diabetes mellitus,HTN ,Asthma
  • Patients with pelvic inflammatory disease when seen associated with prolapsed uterus.
  • 6 Known case of HIV ,VDRL.

结局指标

主要结局

Decrease In Sign And Symptom Of Yonidaha,Yonigat Strav,Katishoola,Ruja

时间窗: 7 Days

次要结局

  • Significant Decrease In Sign And Symptom Of Yonidaha,Yonigat Strav,Katishool,Ruja(2 Month)

研究者

发起方
Dr.Pallavi Dinkar Kamthe
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

DrPallavi Dinkar Kamthe

LRP Ayurvedic Medical College and Hospital PG Institute and Research Centre Urun Islampur

研究点 (1)

Loading locations...

相似试验